Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan.

Nurtazina, Alma; Kozhakhmetova, Dana; Dautov, Daulet; Shakhanova, Aizhan; Chattu, Vijay Kumar

Nurtazina, Alma; Kozhakhmetova, Dana; Dautov, Daulet; Shakhanova, Aizhan; Chattu, Vijay Kumar.

Afiliação

Nurtazina A; Department of Epidemiology and Biostatistics, Semey Medical University, Semey 071400, Kazakhstan.
Kozhakhmetova D; Department of Propedeutics of Internal Diseases, Semey Medical University, Semey 071400, Kazakhstan.
Dautov D; Department of Propedeutics of Internal Diseases, Kazakh National Medical University, Almaty 050000, Kazakhstan.
Shakhanova A; Department of Propedeutics of Internal Diseases, Semey Medical University, Semey 071400, Kazakhstan.
Chattu VK; Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.

Diagnostics (Basel) ; 10(8)2020 Jul 23.

Article em En | MEDLINE | ID: mdl-32717783

Palavras-chave

Kazakhstan; apolipoprotein A1; apolipoprotein B; cardiovascular diseases; high-density lipoprotein cholesterol (HDL-C); hypertension; metabolic syndrome; multiple regression; smoking; triglycerides

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google